Difference between revisions of "Portal:Science/News"
| Line 2: | Line 2: | ||
== Did you know? == | == Did you know? == | ||
| − | [[File:resizdDNA genes.JPG|left|200px]] | + | [[File:resizdDNA genes.JPG|left|200px]]>Right now a case is being heard before the United States Supreme Court on whether a gene sequence known to cause breast cancer (BRCA 1 and BRCA 2) can be patented by one company. This is one of the cases where the social and ethical implications of scientific discoveries have come to the fore. A private company has argued that since it "discovered" these genes only they could develop and administer tests for this gene. This, of course, means that many women will have no access to such potentially life-saving diagnostic strategies. Further this would hinder the progress of science itself as entities other than the patent holder would not be allowed to study or observe genes. This case is being heard by the court now and the pharmaceutical company is being opposed by public interest groups and association of scientists. For more information you can access the argument [http://www.americanbar.org/content/dam/aba/publications/supreme_court_preview/briefs-v2/12-398_neither_amcu_lander.authcheckdam.pdf here]. |
''Image Acknowledgement: http://geneed.nlm.nih.gov/index.php'' | ''Image Acknowledgement: http://geneed.nlm.nih.gov/index.php'' | ||
Revision as of 06:52, 31 May 2013
Did you know?
>Right now a case is being heard before the United States Supreme Court on whether a gene sequence known to cause breast cancer (BRCA 1 and BRCA 2) can be patented by one company. This is one of the cases where the social and ethical implications of scientific discoveries have come to the fore. A private company has argued that since it "discovered" these genes only they could develop and administer tests for this gene. This, of course, means that many women will have no access to such potentially life-saving diagnostic strategies. Further this would hinder the progress of science itself as entities other than the patent holder would not be allowed to study or observe genes. This case is being heard by the court now and the pharmaceutical company is being opposed by public interest groups and association of scientists. For more information you can access the argument here.
Image Acknowledgement: http://geneed.nlm.nih.gov/index.php